DocGo Inc DCGO.OQ DCGO.O is expected to show a fall in quarterly revenue when it reports results on February 27 for the period ending December 31 2024
The New York City-based company is expected to report a 35.0% decrease in revenue to $129.424 million from $199.25 million a year ago, according to the mean estimate from 7 analysts, based on LSEG data.
LSEG's mean analyst estimate for DocGo Inc is for earnings of 5 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for DocGo Inc is $6.50, above its last closing price of $4.44.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | 0.04 | 0.05 | 0.05 | Met | 2.9 |
Jun. 30 2024 | 0.06 | 0.08 | 0.07 | Missed | -6.7 |
Mar. 31 2024 | 0.07 | 0.08 | 0.10 | Beat | 22.8 |
Dec. 31 2023 | 0.09 | 0.10 | 0.07 | Missed | -30 |
Sep. 30 2023 | 0.05 | 0.06 | 0.05 | Missed | -18.9 |
Jun. 30 2023 | 0.03 | 0.03 | -0.02 | Missed | -166.7 |
Mar. 31 2023 | 0.02 | 0.02 | -0.03 | Missed | -238.4 |
Dec. 31 2022 | 0.05 | 0.08 | Beat | 60 |
This summary was machine generated February 25 at 21:30 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。